Published in Law and Health Weekly, February 5th, 2005
"This is a significant milestone for Grant Life Sciences," said Stan Yakatan, the company's chairman and CEO. "No doubt, this patent allowance clears the way for us to aggressively pursue additional valid and enforceable rights in this area of peptides for detecting and/or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.